Bell Investment Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Bell Investment Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.28K	Buy	8 +2	+33%	+$589	﹤0.01%	1294
2026 Q1	$1.78K	Sell	6 -29	-83%	-$9.39K	﹤0.01%	1369
2025 Q4	$10.6K	Buy	35 +33	+1,650%	+$10.8K	﹤0.01%	674
2025 Q3	$682	Buy	+2	New	+$607	﹤0.01%	1662
2024 Q2	–	Sell	-6	Closed	-$939	–	1984
2024 Q1	$939	Hold	6	–	–	﹤0.01%	1621
2023 Q4	$1.08K	Buy	6 +3	+100%	+$543	﹤0.01%	1566
2023 Q3	$540	Hold	3	–	–	﹤0.01%	1760
2023 Q2	$535	Sell	3 -2	-40%	-$461	﹤0.01%	1822
2023 Q1	$1.08K	Hold	5	–	–	﹤0.01%	1538
2022 Q4	$1.1K	Buy	5 +3	+150%	+$550	﹤0.01%	1532
2022 Q3	$0	Hold	2	–	–	﹤0.01%	1996
2022 Q2	$0	Buy	+2	New	+$312	﹤0.01%	1858
2021 Q4	$1K	Hold	2	–	–	﹤0.01%	1677
2021 Q3	$1K	Buy	+2	New	+$654	﹤0.01%	1628

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bell Investment Advisors's ONC Position: Q2 2026 in Review

Bell Investment Advisors increased its BeOne Medicines Ltd (ONC) stake by 33% in Q2 2026, buying an estimated $589 and bringing the position to 8 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Bell Investment Advisors first reported a position in ONC in Q3 2021 and has held it in 14 quarters since. The position peaked at $10.6K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Bell Investment Advisors held 8 shares of BeOne Medicines Ltd worth $2.28K as of Q2 2026.
Bell Investment Advisors bought 2 BeOne Medicines Ltd shares in Q2 2026, an estimated $589.
BeOne Medicines Ltd made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1294 holding.
Bell Investment Advisors first reported a position in BeOne Medicines Ltd in Q3 2021 and has held it in 14 quarters since.
Bell Investment Advisors's BeOne Medicines Ltd position peaked at $10.6K in Q4 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.